Assessment of Endocan Serum Levels in Patients With Behcet Disease

Behçet Clinical Trial

Official title: Assessment of Endocan Serum Levels in Patients With Behcet Disease: Relation to Clinical Parameters and Disease Status

Status Completed

Clinical Trial Summary

The aim of our study was to assess serum endocan levels in patients with Behcet disease and to correlate it with various disease clinical and laboratory parameters of disease activity as well as carotid intima media thickness.

Clinical Trial Description

This study will be carried out on two groups:

• Group (I): Forty two patients diagnosed to have Behcets disease fulfilling the International Criteria for BD .

Group (II): including 42 age and sex matching healthy volunteers as control group.

(A) Clinical evaluation

1. Complete history taking.

2. Thorough clinical examination including opthalmologic evaluation .

3. Disease activity using The Behcet's disease current activity form (BD-DAF) . (B) Laboratory assessment:

All patients will be subjected to the following measurements:

1. ESR

2. CRP

3. CBC

4. liver and kidney function tests

d) Serum Endocan level e)triglycrides f) cholestrol C) carotid intima media thickness ;

Related Conditions & MeSH terms

• Behçet
• Behcet Syndrome

• NCT number: NCT03853135
• Study type: Observational
• Source: Benha University
• Status: Completed
• Start date: February 27, 2019
• Completion date: December 16, 2019